Galanthamine (GAL) is a drug used for the treatment of several neurodegenerative diseases, namely the symptomatic treatment of Alzheimer’s disease at mild, moderate, and advanced-moderate stages, which improves global and cognitive symptoms [22]. Here, GAL is linked to early-onset autosomal dominant Alzheimer disease.